Oversee: Sebetralstat Launch | HCP Marketing | Marketing Operations | Commercial Program Management

Pharma consulting and other business ventures

US Commercial Operations & Business Solutions (COBS) leadership team member responsible for launch strategy and management of COBS 18 product portfolio across 4 BU’s. Managing cross-functional teams in a matrix organization including Sales Operations, Learning & Development, Data Strategy, Marketing Operations, Commercial Planning, Analytics & Forecasting, and Professional Engagements. • • Spearheaded the establishment of a department from the ground up, meticulously crafting its capabilities, assembling a high-caliber team, and empowering the delivery of launch efforts that are precisely tailored for each launch• Leads a high performing team of COBS Launch Leads that operate cross functionally to provide strategic advisement (finance, launch planning, people management, Comm. Ops. strategy and launch excellence (LX)), leadership and enabling on time or earlier launch deliverables • Demonstrates success in expanding team responsibilities into in-line, cross-vertical/function leadership roles for large-scale projects (Hummingbird, BP evolution, Yoda, Momentum, PDT PoC, etc.)• Provides mentorship to launch leads throughout launch programs• Participates as leadership member of USBU LX team to enhance USBU LX capabilities

Strategic partner aligned to COO to lead Business Operations Committee (BOC), USBU Launch Excellence, offshoot BOC committees, leadership in USBU governance process, and a variety of Executive Leadership Team (ELT) projects.• Led cross-BU projects, including USBU LX, USCO LX - Project COBALT, USCO Livtencity Launch team, developed ELT/BOC Governance Framework, created and standardized BU SI/KPI process, served as liaison for CLDP BU, and supported ad hoc requests from COO• Engaged in governance responsibilities, including BOC, COVID Task Force, Data & Digital Council, USBU Patient Engagement SteerCo

Chief of Staff responsibilities and member of the NSBU LT that provided leadership in Marketing, Business & Financial Cycle Planning, Business Performance, Governance, priority BU/Comm. Ops. projects, and other key business advisement.• Participated in special projects including Dengue launch, ongoing neuroscience strategic marketing consultation, OCE structure/department creation, BOC, and Powerful Presentation Facilitator• Held financial planning responsibilities for P&L, IR, LRF, MYC, MRP, and ad hoc requests• Managed cross-functional governance responsibilities, including BOC, XFT, XLT NSBU LT, SI/KPI, LU Alliance, and ad hoc requests

Under new Takeda structure, role focused on leading the HCP ADHD portfolio strategy and providing tactical leadership for the newly developed Multichannel Marketing Team. • Held strategic responsibility for partnering with the depression marketing team for a portfolio approach, creating a new campaign, managing new-hire marketing competencies, brand plan, and enhancements to positioning, messaging, targeting, segmentation, SI/KPI, field strat., etc.• Participated in special projects, including designing MCM structure, created and facilitated marketing training, onboarded Takeda NSBU leadership/marketers/sales, and LOE planning

Leading a sales team of 10 direct reports. Utilized effective hiring and performance management process to assemble a best in class selling team. Drove a motivated and competitive culture to deliver sales performance, exceptional execution, and a fiercely collaborative mindset. Individualize motivation, coaching and training efforts base on representatives’ strengths and weaknesses.

Managed ADHD & B.E.D. indications, led strategy (DS & product), and tactical implementation (personal promo./NPP/DTC) to grow the third-most prescribed branded medication in the nation.• Acquired disease state (DS) strategy and execution, leading to a market volume increase of 20%; Increased volume was the result of a new strategy and DS campaign to drive market growth. • Held branded responsibilities for new branded portfolio campaign, positioning, messaging, targeting, SI/KPI, label strategy, segmentation, call planning, media strategy, publication planning, training, PR, P2P, sales strategy, brand plan, budget, S&OP national/global responsibilities, etc.• Contributed to Vyvanse annual growth increase from $1.5B to $2.5B during tenure as Vyvanse brand leads

Acquired consumer ADHD strategy and execution (personal/non-personal promotion) to continue growth of a $2+ billion-dollar product.• Expanded breadth and depth of marketing experience to include consumer strategy and tactical execution, responsibilities included: patient journey, patient segmentation, advocacy, messaging, digital enablement, social, adherence plan, educational campaigns, new brand campaigns, new DS campaign, DTC, pioneering AI utilization through chatbots, budget management, brand-connected marketing, etc.

Increased scope and responsibilities to include strategy and execution of all Vyvanse ADHD indications.

Established newly developed position through building strategy and implementation (personal/non-personal promotion) to protect and expand the Vyvanse pediatric business.• Led all strategy and execution including but not limited to - new campaigns, positioning, messaging, targeting, KPI, label strategy, segmentation, call planning, media strategy, publication planning, cross-functional responsibilities, P2P, sales meeting planning, field strategy, competitive strategy, brand plan, and manage the budget• Launch lead for new administration (15% volume growth and drastically disrupted HCP Ped. prescribing behaviors), LTME indication, and advising on Mydayis launch strategyAwards:PM360 - 2017 Trailblazer Initiative Gold Award: HCP Education Program

Led B.E.D. team, developed strategic plan, and executed personal and non-personal promotion. Due to similarities of RD markets, B.E.D. strategy and tactics were modeled after rare disease approaches. • Launch lead for the LTME indication• Resulted in reducing the time to Dx by 50%, growing brand volume +17.4%, share +1.2% and generating +20% in sales• Led all strategy and execution including but not limited to, new campaign, market development, patient finding, positioning, messaging, targeting, label strategy, segmentation, publication planning, P2P, sales meeting planning, field strategy, brand plan, and manage the budget• Led industry-first patient ambassador speaker program to HCP audience; Beating previous P2P attendance record

Primary Role: The Brand Manager leads the development, implementation and management of programs, services and tactics for HCP customer segment and/or key initiatives in collaboration with other members of the brand team and relevant internal stakeholders. In particular, this role focuses on developing and implementing area-specific communications, programs, services and resources. As part of the marketing team, this role shares responsibility for achieving revenue, market share and A&P expense targets, and is responsible for managing the budget for my areas of accountability, including budget phasing. In delivering against assigned objectives, the role collaborates and integrates extensively with other members of the marketing team, the field sales team and multiple other internal functions. The role also requires flexibility to respond to requests from leadership to support various key projects and initiatives that may arise.Awards:-PM360 2016 Trailblazer Initiative Award- Interactive Marketing Program

Primary Role Contribute to achieving national sales goals by effectively implementing marketing strategies and sales plan in assigned region. Provide current, accurate and meaningful product information to physicians, nurses, pharmacists, and other customers, for the primary purpose of selling Shire brands and their benefits to customers. 2015 Promoted to Field Sales Trainer/Zone Development TeamAdditional Team Roles-new hire training -analytics -presentations at meetings-vacant territory coverage NATIONAL AWARDS & HONORS-Impact Award (driving sales results and leadership): Q1 2014, Q1 2015, Q2 2015-Number 1 representative in the state: 2011, 2012, 2014 -Representative of the Quarter (no longer awarded after Q2 2013)- Q2 2011, Q4 2011, Q1 2012, Q2 2012, Q3 2012, Q4 2012-Kicker Bonus (available from Q1 to Q3 2014): Q1 2014 (only 15% of nation received this payout), Q2 2014 (10% of nation received this payout)-150% Bonus Kicker (available from Q4 2014 to Q1 2015): received kicker during each quarter along with additional bonus kicker for being over 102% of goal (secondary kicker only offered during Q1 2015)-Special Incentive- Top 20 representatives in the zone: Q4 2008, Q1 2009, Q2 2009, Q2 2011, Q4 2011 (this bonus is no longer available after Q4 2011) -Dash to the Finish Competition- 1st place in Q4 2008 -iPrescriber Challenge- 2nd place in Q2 2010 -Added Difference Challenge- Awarded top prize payout in Q2 2011 -Portfolio Growth Challenge- 3rd Place in Q4 2010REGIONAL AWARDS & HONORS 2014-Sales Endurance 1H 2014 -Multiple Leadership Achievements-Multiple Analytic Achievements